-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price shot up 3.4% during mid-day trading on Wednesday . The company traded as high as $7.35 and last traded at $7.32. 441,126 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 3,376,665 shares. The stock had previously closed at $7.08.
Mind Medicine (MindMed) Price Performance
The company’s fifty day moving average is $7.22 and its 200 day moving average is $6.98.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- Investing in the High PE Growth Stocks
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Reddit Stock Dominated 2024—Why the Rally Isn’t Over Yet
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Investing in Sustainable Solutions: 2 Top Water Tech Stocks
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
